Home
Lars T. Fadnes's picture
Photo:
Jørgen Barth

Lars T. Fadnes is a professor at Department of Global Public Health and Primary at the University of Bergen and research group leader at Haukeland university hospital. He is a medical doctor and is a specialist in general practice as well as having a diploma in tropical medicine and hygiene. Fadnes has worked with research on dietary patterns and associations with chronic diseases and has had substantial international collaboration with researchers from the United Kingdom, Uganda, South Africa, Italy, Australia, the United States, with external funding from the Research Council of Norway, the Western Norway Regional Health Authority and DAM. His research spans across several themes, mostly focusing on nutrition and associations to chronic diseases, substance use and migration. Fadnes has more than a hundred scientific publications published in international peer-reviewed journals, as well as being covered in many hundred newspaper stories. He has also been central in development of guidelines both nationally and internationally relating to both nutrition and treatment of people with substance use. He is part of the Norwegian national advisory panel on nutrition (Nasjonalt råd for ernæring) and the Norwegian scientific committee for food and environment (VKM). He has received awards for research and innovation including the Meltzer award for excellence in the dissemination of research (2022), Young researcher award for health research in Western Norway 2021, Falch junior award for medical research 2021, and prize for research and innovation 2020 (Kunnskapskommunene), and has several articles on the Altmetric top rank list. He is the leader of HEMIX research group and Bergen Addiction Research, is co-founder of the Norwegian competence centre for substitution therapy (NORCATS), has supervised/is supervising >15 candidates (including 7 who has completed and 6 as main supervisor).

Diet and nutrition 
Eating and prevention of chronic diseases.

Clinical teaching in family medicine
Clinical teaching in family medicine and supervision of medical students and doctors.

Treatment and health outcomes linked to health care structure among people with substance use
Treatment of hepatitis C linked to health system and structure and impact on health outcomes in terms of quality of life, mortality, satisfaction with health care. 

Immigrant health
Health services use, morbidity and medication of immigrants. 

Experimental and observational epidemiology
Analysing and interpreting experimental and observational research. 

Academic article
  • Show author(s) (2024). Update of statistical analysis plan for: Integration of smoking cessation into standard treatment for patients receiving opioid agonist therapy who are smoking tobacco: protocol for a randomised controlled trial (ATLAS4LAR). Trials.
  • Show author(s) (2024). The association of psychological distress and economic and health worries with tobacco smoking behavior during the COVID-19 pandemic: a two-year longitudinal cohort study. BMC Public Health.
  • Show author(s) (2024). Physical activity and sedentary time after lifestyle interventions at the Norwegian Healthy Life Centres. Primary Health Care Research and Development. 8 pages.
  • Show author(s) (2024). Methadone pharmacokinetics in opioid agonist treatment: Influencing factors and clinical implications. Basic & Clinical Pharmacology & Toxicology. 333-344.
  • Show author(s) (2024). Effect of integrated hepatitis C virus treatment on psychological distress in people with substance use disorders. Scientific Reports.
  • Show author(s) (2023). Validation of a brief version of the Difficulties in Emotion Regulation Scale (DERS-16) with an older Norwegian population. European Journal of Ageing.
  • Show author(s) (2023). The efficacy of integrated hepatitis C virus treatment in relieving fatigue in people who inject drugs: a randomized controlled trial. Substance Abuse Treatment, Prevention, and Policy.
  • Show author(s) (2023). The association between psychological distress and alcohol consumption and physical activity: a population-based cohort study. Frontiers in Psychiatry. 13 pages.
  • Show author(s) (2023). Risk of relapse to non-opioid addictive substances among opioid dependent patients treated with an opioid receptor antagonist or a partial agonist: A randomized clinical trial. Contemporary Clinical Trials. 9 pages.
  • Show author(s) (2023). Perceived Change in Quality of Life Related to Treatment of Hepatitis C Infection among People with Substance Use Disorder: A Qualitative Study. Health and Social Care in the Community. 9 pages.
  • Show author(s) (2023). Needs for help and received help for those bereaved by a drug-related death: a cross-sectional study. Nordic Studies on Alcohol and Drugs (NAD). 463-481.
  • Show author(s) (2023). Life expectancy can increase by up to 10 years following sustained shifts towards healthier diets in the United Kingdom. Nature Food. 961-965.
  • Show author(s) (2023). Emotional Eating and Changes in High-Sugar Food and Drink Consumption Linked to Psychological Distress and Worries: A Cohort Study from Norway. Nutrients. 14 pages.
  • Show author(s) (2023). Drug Death-Bereaved Parents’ Perspectives on Family Interactions and Help Needs: A Qualitative Study. Contemporary family therapy.
  • Show author(s) (2023). Cost-effectiveness of integrated treatment for hepatitis C virus (HCV) among people who inject drugs in Norway: An economic evaluation of the INTRO-HCV trial. Addiction. 2424-2439.
  • Show author(s) (2023). Changes in Body Mass Index and Their Associations with Psychological Distress, Worries, and Emotional Eating during the COVID-19 Pandemic: A Norwegian Cohort Study. Nutrients. 1-13.
  • Show author(s) (2023). Behandling av hepatitt C og endringer i rusmiddelbruk – en kvalitativ studie. Sykepleien Forskning.
  • Show author(s) (2023). Attention-deficit/hyperactivity disorder (ADHD) symptoms and their relation to diagnosed ADHD, sociodemographic characteristics, and substance use among patients receiving opioid agonist therapy: a Norwegian cohort study. BMC Psychiatry.
  • Show author(s) (2023). A qualitative study on people with opioid use disorders’ perspectives on smoking and smoking cessation interventions. Frontiers in Psychiatry.
  • Show author(s) (2022). Vitamin D status and associations with substance use patterns among people with severe substance use disorders in Western Norway. Scientific Reports. 1-9.
  • Show author(s) (2022). Vitamin B12 Levels, Substance Use Patterns and Clinical Characteristics among People with Severe Substance Use Disorders: A Cohort Study from Western Norway. Nutrients. 10 pages.
  • Show author(s) (2022). The social health domain of people bereaved by a drug-related death and associations with professional help: a cross-sectional study. Death Studies. 1-12.
  • Show author(s) (2022). Quality of life among young people in Norway during the COVID‑19 pandemic. A longitudinal study. European Child and Adolescent Psychiatry. 11 pages.
  • Show author(s) (2022). Prevalence and correlates of suicide attempts in high-risk populations: a cross-sectional study among patients receiving opioid agonist therapy in Norway. BMC Psychiatry. 8 pages.
  • Show author(s) (2022). Parental stress during the COVID-19 pandemic: A one-year follow-up. PLOS ONE. 1-16.
  • Show author(s) (2022). Integration of smoking cessation into standard treatment for patients receiving opioid agonist therapy who are smoking tobacco: protocol for a randomised controlled trial (ATLAS4LAR). Trials.
  • Show author(s) (2022). Increased gaming during COVID-19 predicts physical inactivity among youth in Norway - a two-wave longitudinal cohort study. Frontiers in Public Health. 1-8.
  • Show author(s) (2022). Impact of liver fibrosis and clinical characteristics on dose-adjusted serum methadone concentrations. Journal of Addictive Diseases. 11 pages.
  • Show author(s) (2022). Folate Status as a Nutritional Indicator among People with Substance Use Disorder; A Prospective Cohort Study in Norway. International Journal of Environmental Research and Public Health (IJERPH).
  • Show author(s) (2022). Facilitators for use of oral healthcare services among people with substance use disorders: a qualitative study in Norway. Acta Odontologica Scandinavica.
  • Show author(s) (2022). Experiences of hope after treatment of hepatitis C infection - A qualitative study. International Journal of Environmental Research and Public Health (IJERPH). 1-13.
  • Show author(s) (2022). Estimating impact of food choices on life expectancy: A modeling study. PLoS Medicine.
  • Show author(s) (2022). Effect of a self-help group intervention using Teaching Recovery Techniques to improve mental health among Syrian refugees in Norway: a randomized controlled trial. International Journal of Mental Health Systems. 11 pages.
  • Show author(s) (2022). Consumption of Nuts and Seeds and Health Outcomes Including Cardiovascular Disease, Diabetes and Metabolic Disease, Cancer, and Mortality: An Umbrella Review. Advances in Nutrition. 2136-2148.
  • Show author(s) (2022). Association between oral and general health related quality of life among Norwegian patients with substance use disorders in opioid agonist therapy. Acta Odontologica Scandinavica. 332-339.
  • Show author(s) (2021). Validation of a three-item Fatigue Severity Scale for patients with substance use disorder: a cohort study from Norway for the period 2016–2020. Health and Quality of Life Outcomes. 10 pages.
  • Show author(s) (2021). The prevalence and socio-behavioural and clinical covariates of oral health related quality of life in Ugandan mothers with and without HIV-1. Health and Quality of Life Outcomes. 1-19.
  • Show author(s) (2021). The Predictive Value of Degree of Preference for Extended-Release Naltrexone for Treatment Adherence, Opioid Use, and Relapse. European Addiction Research. 56-67.
  • Show author(s) (2021). Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway. Substance Abuse Treatment, Prevention, and Policy. 10 pages.
  • Show author(s) (2021). Subjective symptoms and serum methadone concentrations: what should guide dose adjustments in methadone maintenance treatment? A naturalistic cohort study from Norway. Substance Abuse Treatment, Prevention, and Policy. 1-8.
  • Show author(s) (2021). Risk of Relapse Among Opioid-Dependent Patients Treated With Extended-Release Naltrexone or Buprenorphine-Naloxone: A Randomized Clinical Trial. American Journal on Addictions. 453-460.
  • Show author(s) (2021). Restless legs syndrome - a study from general practice. Tidsskrift for Den norske legeforening. 12 pages.
  • Show author(s) (2021). Psychometric Properties of the Norwegian Version of the Fear of COVID-19 Scale. International Journal of Mental Health and Addiction. 1-19.
  • Show author(s) (2021). Perceived consequences and worries among youth in Norway during the COVID-19 pandemic lockdown. Scandinavian Journal of Public Health. 755-765.
  • Show author(s) (2021). Oral health related quality of life and reasons for non-dental attendance among patients with substance use disorders in withdrawal rehabilitation. Clinical and Experimental Dental Research. 1-8.
  • Show author(s) (2021). Non-financial barriers in oral health care: a qualitative study of patients receiving opioid maintenance treatment and professionals’ experiences. Substance Abuse Treatment, Prevention, and Policy. 11 pages.
  • Show author(s) (2021). Life satisfaction among individuals with opioid use disorder receiving extended-release naltrexone: A 12-week randomized controlled trial and a 36-week follow-up. Journal of Substance Abuse Treatment. 8 pages.
  • Show author(s) (2021). Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV). PLoS Medicine. 17 pages.
  • Show author(s) (2021). How the Norwegian population was affected by non-pharmaceutical interventions during the first six weeks of the COVID-19 lockdown. Scandinavian Journal of Public Health. 1-8.
  • Show author(s) (2021). Effectiveness and safety of low-threshold opioid-agonist treatment in hard-to-reach populations with opioid dependence. European Addiction Research. 1-11.
  • Show author(s) (2021). Changes in substance use during outpatient treatment for substance use disorders: a prospective Norwegian cohort study from 2016 to 2020. Substance Abuse Treatment, Prevention, and Policy. 1-9.
  • Show author(s) (2021). Caries experience by socio-behavioural characteristics in HIV-1-infected and uninfected Ugandan mothers – a multilevel analysis. Acta Odontologica Scandinavica. 8 pages.
  • Show author(s) (2021). Alcohol Consumption during a Pandemic Lockdown Period and Change in Alcohol Consumption Related to Worries and Pandemic Measures. International Journal of Environmental Research and Public Health (IJERPH). 11 pages.
  • Show author(s) (2020). Uptake and predictors of direct-acting antiviral treatment for hepatitis C among people receiving opioid agonist therapy in Sweden and Norway: a drug utilization study from 2014 to 2017. Substance Abuse Treatment, Prevention, and Policy.
  • Show author(s) (2020). Too much or too little opioids to patients receiving opioid agonist therapy in Norway (2013-2017): a prospective cohort study. BMC Health Services Research. 10 pages.
  • Show author(s) (2020). The effect of physiotherapy group intervention in reducing pain disorders and mental health symptoms among syrian refugees: A randomized controlled trial. International Journal of Environmental Research and Public Health (IJERPH). 15 pages.
  • Show author(s) (2020). Potentially addictive drugs dispensing to patients receiving opioid agonist therapy: a register-based prospective cohort study in Norway and Sweden from 2015 to 2017. BMJ Open. 10 pages.
  • Show author(s) (2020). On the path towards universal coverage of hepatitis C treatment among people receiving opioid agonist therapy (OAT) in Norway: A prospective cohort study from 2013 to 2017. BMJ Open. 1-9.
  • Show author(s) (2020). Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016–2020. Substance Abuse Treatment, Prevention, and Policy. 11 pages.
  • Show author(s) (2020). Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway. Substance Abuse Treatment, Prevention, and Policy. 1-12.
  • Show author(s) (2020). Health status and use of medication and their association with migration related exposures among Syrian refugees in Lebanon and Norway: a cross-sectional study. BMC Public Health. 1-9.
  • Show author(s) (2020). Dispensations of benzodiazepines, z-hypnotics, and gabapentinoids to patients receiving opioid agonist therapy; A prospective cohort study in Norway from 2013 to 2017. BMC Health Services Research. 1-12.
  • Show author(s) (2020). Dispensation of attention deficit hyperactivity disorder (ADHD) medications in patients receiving opioid agonist therapy; A national prospective cohort study in Norway from 2015 to 2017. BMC Psychiatry. 1-12.
  • Show author(s) (2020). Dental health care workers’ attitude towards patients with substance use disorders in medically assisted rehabilitation (MAR). . Acta Odontologica Scandinavica. 31-36.
  • Show author(s) (2020). Changes in health among Syrian refugees along their migration trajectories from Lebanon to Norway: a prospective cohort study. Public Health. 240-245.
  • Show author(s) (2020). Caries experience and oral health related quality of life in a cohort of Ugandan HIV-1 exposed uninfected children compared with a matched cohort of HIV unexposed uninfected children. BMC Public Health. 1-12.
  • Show author(s) (2020). Association of maternal HIV‐1 severity with dental caries: an observational study of uninfected 5‐ to 7‐yr‐old children of HIV‐1‐infected mothers without severe immune suppression. European Journal of Oral Sciences. 46-54.
  • Show author(s) (2020). Antiretroviral treatment and its impact on oral health outcomes in 5 to 7 year old Ugandan children: A 6 year follow-up visit from the ANRS 12174 randomized trial. Medicine. 1-8.
  • Show author(s) (2020). Emotional Eating in Relation to Worries and Psychological Distress Amid the COVID-19 Pandemic: A Population-Based Survey on Adults in Norway. International Journal of Environmental Research and Public Health (IJERPH). 10 pages.
  • Show author(s) (2019). Two interventions to treat pain disorders and post-traumatic symptoms among Syrian refugees: protocol for a randomized controlled trial. Trials. 1-9.
  • Show author(s) (2019). Peer involvement and cross-sector efforts in establishing integrated treatment of hepatitis C virus infection for people with substance use disorders: experiences from Norway. Substance Abuse Treatment, Prevention, and Policy. 1-7.
  • Show author(s) (2019). Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV). BMC Infectious Diseases. 1-9.
  • Show author(s) (2018). Dietary intake and blood concentrations of antioxidants and the risk of cardiovascular disease, total cancer, and all-cause mortality: A systematic review and dose-response meta-analysis of prospective studies. American Journal of Clinical Nutrition. 1069-1091.
  • Show author(s) (2017). Primary healthcare usage and use of medications among immigrant children according to age of arrival to Norway: A population-based study. BMJ Open. 1-9.
  • Show author(s) (2017). Predicting undernutrition at age 2 years with early attained weight and length compared with weight and length velocity. Journal of Pediatrics. 127-132.e1.
  • Show author(s) (2017). Fruit and vegetable intake and the risk of cardiovascular disease, total cancer and all-cause mortality-A systematic review and dose-response meta-analysis of prospective studies. International Journal of Epidemiology. 1029-1056.
  • Show author(s) (2017). Country, regional, and global estimates for lactose malabsorption in adults: a systematic review and meta-analysis. The Lancet Gastroenterology and Hepatology. 738-746.
  • Show author(s) (2017). Assessing causal effects of early life course factors on early childhood caries in 5-year-old Ugandan children using Direct acyclic graphs (DAGs): A prospåective cohort study. Community Dentistry and Oral Epidemiology. 512-521.
  • Show author(s) (2016). Whole grain consumption and risk of cardiovascular disease, cancer, and all cause and cause specific mortality: systematic review and dose-response meta-analysis of prospective studies. The BMJ.
  • Show author(s) (2016). Using growth velocity to predict child mortality. American Journal of Clinical Nutrition. 801-807.
  • Show author(s) (2016). Primary health care utilisation and morbidity among immigrant children compared to non-immigrant children: a population-based study in Norway. BMJ Open. 1-8.
  • Show author(s) (2016). Objectively assessed physical activity and associated factors among adults in peri-urban and rural Eastern Uganda: a population-based study. Journal of Physical Activity and Health. 1243-1254.
  • Show author(s) (2016). Nut consumption and risk of cardiovascular disease, total cancer, all-cause and cause-specific mortality: A systematic review and dose-response meta-analysis of prospective studies. BMC Medicine. 14 pages.
  • Show author(s) (2016). Impact of a peer-counseling intervention on breastfeeding practices in different socioeconomic strata: results from the equity analysis of the PROMISE-EBF trial in Uganda. Global health action.
  • Show author(s) (2016). Effects of an exclusive breastfeeding intervention for six months on growth patterns of 4-5 year old children in Uganda: The cluster-randomised PROMISE EBF trial. BMC Public Health. 9 pages.
  • Show author(s) (2016). Caretaker's caries experience and its association with early childhood caries and children's oral Health related quality of life: a prospective two generation study. Acta Odontologica Scandinavica. 605-612.
  • Show author(s) (2015). Population-based survey of overweight and obesity and the associated factors in peri-urban and rural Eastern Uganda Chronic Disease epidemiology. BMC Public Health.
  • Show author(s) (2015). Effects of early feeding on growth velocity and overweight/obesity in a cohort of HIV unexposed South African infants and children. International Breastfeeding Journal.
  • Show author(s) (2015). Effect of breastfeeding promotion on early childhood caries and breastfeeding duration among 5 year old children in Eastern Uganda: A cluster randomized trial. PLOS ONE.
  • Show author(s) (2015). Cost-effectiveness of peer counselling for the promotion of exclusive breastfeeding in Uganda. PLOS ONE. 18 pages.
  • Show author(s) (2015). Child survival and BCG vaccination: A community based prospective cohort study in Uganda. BMC Public Health. 10 pages.
  • Show author(s) (2014). Impact of low birthweight on early childhood caries in 6-36 months old infants in Uganda: A cross-sectional study. Acta Odontologica Scandinavica. 312-320.
  • Show author(s) (2014). HIV Infection, Viral Load, Low Birth Weight, and Nevirapine Are Independent Influences on Growth Velocity in HIV-Exposed South African Infants. Journal of Nutrition. 42-48.
  • Show author(s) (2014). Growth effects of exclusive breastfeeding promotion by peer counsellors in sub-Saharan Africa: the cluster-randomised PROMISE EBF trial. BMC Public Health. 12 pages.
  • Show author(s) (2014). Early infant feeding practices in three African countries: the PROMISE-EBF trial promoting exclusive breastfeeding by peer counsellors. International Breastfeeding Journal. 19.
  • Show author(s) (2013). Infant feeding survival and Markov transition probabilities among children under age 6 months in Uganda. American Journal of Epidemiology. 453-462.
  • Show author(s) (2012). Timeliness of childhood vaccinations in Kampala Uganda: a community-based cross-sectional study. PLOS ONE. 6 pages.
  • Show author(s) (2012). Early cessation of breastfeeding amongst women in South Africa: an area needing urgent attention to improve child health. BMC Pediatrics. 10 pages.
  • Show author(s) (2011). Vaccination coverage and timeliness in three South African areas: a prospective study. BMC Public Health. 11 pages.
  • Show author(s) (2011). Target weight gain for moderately wasted children during supplementation interventions - a population-based approach. Public Health Nutrition (PHN). 2117-2123.
  • Show author(s) (2011). Is vaccination coverage a good indicator of age-appropriate vaccination? A prospective study from Uganda. Vaccine. 3564-3570.
  • Show author(s) (2011). Exclusive breastfeeding promotion by peer counsellors in sub-Saharan Africa (PROMISE-EBF): a cluster-randomised trial. The Lancet. 420-427.
  • Show author(s) (2010). Infant feeding counselling in Uganda in a changing environment with focus on the general population and HIV-positive mothers - a mixed method approach. BMC Health Services Research. 9 pages.
  • Show author(s) (2009). Need to optimise infant feeding counselling: A cross-sectional survey among HIV-positive mothers in Eastern Uganda. BMC Pediatrics.
  • Show author(s) (2009). Infant feeding among HIV-positive mothers and the general population mothers: comparison of two cross-sectional surveys in Eastern Uganda. BMC Public Health. 14 pages.
Doctoral dissertation
  • Show author(s) (2011). Counselling, child growth and feeding of children in Uganda in the era of HIV: Contexts and consequences.

More information in national current research information system (CRIStin)

Publications listed in PubMed:

http://www.ncbi.nlm.nih.gov/pubmed?term=Fadnes%20LT%20%5Bau%5D

Project leadership

  • 2019--> Food4HealthyLife: Food4HealthyLife is a calculator to estimate impact of food patterns on health outcomes and will suggest impact of various types of food changes giving instant feedback on impact of diet related choices (www.food4healthylife.org) in collaboration with Bergen Centre for Ethics and Priority Setting (BCEPS). The Food4HealthyLife has received funding from DAM of approximately NOK 3 million excluding senior researchers’ salaries.
  • 2019--> Coordinating the multi-centre study ATLAS4OAT study (assessment and treatment of lung disease among patient receiving opioid agonist therapy). This includes three trials (BAReNikotin, FruktBAR, and BAReAktiv). The study is financed by the Helse Vest RHF with funding of approxiimately NOK 19 million (the Western Norway Regional Health Authority). Read more on https://helse-bergen.no/avdelinger/rusmedisin/rusmedisin-seksjon-forsking/bar/atlas4lar-kartlegging-og-behandling-av-lungesykdom-i-legemiddelassistert-behandling.
  • 2016 --> Coordinating the multi-centre study “Integrated treatment of hepatitis C virus infection among patients with injecting drug abuse: a randomised controlled trial (INTRO-HCV)”. The trial compares the effect of integrated hepatitis C (HCV) treatment between the opioid substitution treatment polyclinics in Bergen and Stavanger (intervention arm) with standard treatment provided after referral to infectious disease clinics among patients who receive opioid substitution treatment having HCV. The study is financed by the Norwegian Research Council and Helse Vest RHF (the Western Norway Regional Health Authority)(https://www.cristin.no/app/projects/show.jsf?id=536891, funding of approximately NOK 25 million). See also clinicaltrials.gov no. NCT03155906: https://clinicaltrials.gov/ct2/show/NCT03155906?term=NCT03155906&rank=1
  • 2016/7--> Established regional health register (LAR helseregister) for patients receiving opioid substitution treatment utilised both in Bergen, Stavanger and Sandnes and contributing to setting up a biobank utilised in the same area (Bergen Addiction Research Group biobank). Approved by Datatilsynet and REK Vest.
  • 2017--> Asessment of oral health among patients receiving opioid substitution treatment in Bergen (Tannhelse i LAR). https://app.cristin.no/projects/show.jsf?id=567285

Other involvement in projects

  • 2022--> Coordinating the multi-centre study ATLAS4DEPENDENCE study (clinical trial) together with Kjell Arne Johansson and Fatemeh Chalabianloo (all three are co-PIs). The study is financed by KLINBEFORSK Helse RHF (the Norway Regional Health Authority) with a total research funding of approximately 20 million NOK excluding senior researchers’ salaries.
  • 2021--> Integration for health. The study is financed by the Norwegian Research Council (link to article)
  • 2020--> Bergen in Change (Bergen i endring, BiE studien, co-PI): Bergen in Change is a cohort from Bergen municipality inviting 200 000 inhabitants for assessment of various risk factors and impact on life in relation to various public health measures
  • 2016--> Changing health along the Syrian refugees' trajectories to Norway. Somatic and mental health relationships and implication for treatment. The study is financed by the Norwegian Research Council (https://www.cristin.no/app/projects/show.jsf?id=537853)
  • 2017--> FARBAR: Pharmacology Research project for Bergen Addiction Research Group
  • 2016--> The Methadone project (metadonprosjektet). The study is financed by the Helse Vest RHF (the Western Norway Regional Health Authority)                        (https://helseforskning.etikkom.no/prosjekterirek/prosjektregister/prosjekt?p_document_id=820998)
  • 2016--> SELFIE (Sustainable intEgrated chronic care modeLs for multi-morbidity: delivery, FInancing, and performancE), financed by European Union Horizon 2020 grant agreement No 634288 
  • 2007-2011: PROMISE-EBF: Safety and Efficacy of Exclusive Breastfeeding Promotion in the Era of HIV in Sub-Saharan Africa. Funded by European Union Sixth Framework International Cooperation–Developing Countries, Research Council of Norway, Swedish International Development Cooperation Agency, Norwegian Programme for Development, Research and Education, South African National Research Foundation, and Rockefeller Brothers Foundation. 
  • Clinical specialist in family medicine (2017)
  • PhD-degree from the University of Bergen (2011)
  • Diploma in Tropical Medicine and Hygiene (DTM&H) at LSHTM (2010)
  • Completed medical study (medical doctor/cand.med.) (2009)
  • Complete The Medical Student Research Program (2009)